Drug Search Results

Satavaptan

Alternative Names: satavaptan, sr121463b
Latest Update: 2023-08-24
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: V2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Satavaptan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Heart Failure|Hyponatremia|Liver Cirrhosis|Inappropriate ADH Syndrome|Diabetes Insipidus

Phase 2: Hyponatremia|Liver Cirrhosis|Inappropriate ADH Syndrome|Diabetes Insipidus

Trial	Phase	Trial Status	Disease	Primary Completion Date
SPARe-2	P3	Completed	Liver Cirrhosis	2009-03-03
CATS	P3	Completed	Liver Cirrhosis	2008-12-30
PASCCAL-1	P2	Completed	Liver Cirrhosis	2008-12-03
AQUARIST1	P3	Terminated	Hyponatremia\|Inappropriate ADH Syndrome	2008-12-01

Recent News Events

Date	Type	Title
08/24/2023	PubMed	Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis.
06/21/2023	PubMed	Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study.
11/01/2022	PubMed	Development and validation of the Cirrhotic Ascites Severity model-A patient-reported outcome-based model to predict 1-year mortality.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions